about
Trends and patterns of urodynamic studies in U.S. women, 2000-2012.Trends and Patterns of Urodynamic Studies in U.S. Males, 2000-2012.Incidence of opioid-managed pelvic pain after hysteroscopic sterilization versus laparoscopic sterilization, US 2005-2012.The use of one- versus two-tailed tests to evaluate prevention programs.Trends in Antibiotic Use by Birth Season and Birth Year.Left Truncation Bias to Explain the Protective Effect of Smoking on Preeclampsia: Potential, But How Plausible?Trends in Pharmacotherapy for Bladder Dysfunction Among Children in the United States, 2000 to 2013.Standardized binomial models for risk or prevalence ratios and differences.Hydrogen sulfide concentrations at three middle schools near industrial livestock facilities.Effect of supplementation with a lipid-based nutrient supplement on the micronutrient status of children aged 6-18 months living in the rural region of Intibucá, Honduras.New findings from the Feeding Infants and Toddlers Study 2008.Adverse Drug Reactions Among Patients Enrolled in an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program 2015–2016 at UNC Medical Center.Characterization of Readmissions Among Patients Enrolled in an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program Over a 2-Year Period at UNC Medical Center.Impact of New Medications and $4 Generic Programs on Overactive Bladder Treatment Among Older Adults in the United States, 2000-2015.Inverse-Probability Weights for the Analysis of Polytomous Outcomes.Review: In primary care, CRP testing, shared decision making, and procalcitonin reduce antibiotic prescribing for ARI.Risk factors associated with the presence and severity of food insecurity in rural Honduras.Bias-corrected Estimates of Time-Varying Adverse Drug Event Rates for Patients on Outpatient Parenteral Antimicrobial Therapy (OPAT).Marginal Structural Models for Risk or Prevalence Ratios for a Point Exposure Using a Disease Risk Score
P50
Q35142155-916F0ABA-9446-4852-B52E-DDAB14F9279DQ35702285-A5FA3843-5078-4C2C-A61D-B01F2D12F67EQ35925063-A1058A2E-FB42-4643-A1FB-C3959E326E80Q37817574-DA692F5D-3D71-4ECA-B2C7-A2C44A7F4941Q38625005-60FCE9DA-DD74-4474-8352-7BB036104587Q38987109-E1A27BA1-E2BF-4758-A1CF-BC408C6D5822Q39853460-B3C9B3DA-BA4F-44B4-B0F9-C76BC43AD4E0Q40675524-A0AD8152-8DC5-43DC-8064-B85DFA54B997Q40791408-F16DCD02-6185-4A6E-96D4-D661509D9C53Q44036519-9D041357-013B-40E8-BAAE-AC36530178D3Q45333869-62D8300E-50B6-4263-A44A-A468D88ABCBEQ46196450-1795218E-0779-4227-A7C6-732117F38141Q47137941-573BB16F-CD51-4225-8673-9031212FC9C1Q47234146-2C98F460-D965-4844-8797-C87C6F62FD57Q49489203-9F10D137-6914-45FE-AC00-BCD433FF1F58Q50042013-40AEBA29-7A64-402F-BC2B-5258AD9D1D2FQ50785784-50856629-9931-4297-A077-961570386A25Q53272578-EDED8209-8D3C-4E28-9852-3E5E875202FCQ91380675-7D2462CE-EBDF-4519-A361-3E2A757EC4BA
P50
description
researcher ORCID ID = 0000-0002-4279-8685
@en
name
Alan C Kinlaw
@ast
Alan C Kinlaw
@en
Alan C Kinlaw
@es
Alan C Kinlaw
@nl
type
label
Alan C Kinlaw
@ast
Alan C Kinlaw
@en
Alan C Kinlaw
@es
Alan C Kinlaw
@nl
prefLabel
Alan C Kinlaw
@ast
Alan C Kinlaw
@en
Alan C Kinlaw
@es
Alan C Kinlaw
@nl
P31
P496
0000-0002-4279-8685